With Dow 22,000 alerting Main Street investors to the fact stocks are at record highs, its a good time to reiterate that August has been the worst-performing month for the Dow the past 20 years. The Dow has fallen 1.4%, on average, in August and finished up just 50% of the time.
So what events in August could derail the Dows record run? LPL Financials chief wealth strategist Matthew Peterson and senior market strategist Ryan Detrick compiled a watch list:
Jobs report: The July employment report will be released Friday. Wall Street is looking for a continuation of the upbeat report in June, when the economy created 222,000 jobs. LPL is expecting 180,000 new jobs in August.
Inflation update: The Federal Reserve has hiked interest rates twice this year. But tepid inflation in recent months has complicated its future hike plans. On Aug. 11, investors will get a look at July inflation at the consumer level. If it is weak and stays south of the Feds 2% goal, the rate-hike schedule could be pushed back.
Top Performing Stocks To Own Right Now: Benchmark Electronics, Inc.(BHE)
- [By Anders Bylund]
How do you pick the top names in this broadly lucrative industry? I’m here to show you my three favorites in the printed circuit board market: Sanmina (NASDAQ:SANM), Benchmark Electronics (NYSE:BHE), and TTM Technologies (NASDAQ:TTMI), each one tailor-made for a different type of investor.
Top Performing Stocks To Own Right Now: Express-1 Expedited Solutions Inc.(XPO)
- [By WWW.THESTREET.COM]
With a trailing 12-month price-to-earnings ratio of 28.79, FedEx’s valuation is in line with UPS (27.52) and far cheaper than XPO Logistics (XPO) (90.25).
- [By WWW.THESTREET.COM]
In the Lightning Round, Cramer was bullish on GlaxoSmithKline (GSK) , Chubb (CB) , XPO Logistics (XPO) , FedEx (FDX) and Nordson (NDSN) .
Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .
Top Performing Stocks To Own Right Now: Chimerix, Inc.(CMRX)
- [By WWW.MONEYSHOW.COM]
The lead product candidate from Chimerix (CMRX) is brincidofovir (CMX001), a nucleotide analog.
The drug is in Phase III clinical trials for the prevention of cytomegalovirus (CMV) in allogeneic hematopoietic cell transplant (HCT) recipients and in kidney transplant recipients, as well as to treat adenovirus infection in allogeneic HCT patients.
Top Performing Stocks To Own Right Now: BiondVax Pharmaceuticals Ltd.(BVXV)
- [By Chris Lange]
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) reported that the scientific journal “Vaccine” published an article citing results from its flu vaccine. The “Vaccine” article, Back to the future: Immunization with M-001, reports that blood plasma samples from people who received M-001 in 2011 (as part of BiondVax’s BVX-005 clinical trial in the elderly) showed significantly increased protective antibodies against the new epidemic 2014/15 flu strain (A/Swiss) – a strain which did not exist when M-001 was administered to the BVX-005 participants.